中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2009年
5期
821-822
,共2页
肺心病%甲状腺素
肺心病%甲狀腺素
폐심병%갑상선소
Pumonary heart disease%Thyroid hormones
目的 探讨肺源性心脏病(肺心病)急性加重期患者甲状腺功能的变化特点及意义.方法 肺心病急性加重期200例作为观察组,同期健康体检者200例作为对照组,观察正常甲状腺病态综合征(ESS)发生情况,对比对照组与观察组中存活、病死患者的甲状腺素水平,ESS者治疗前后甲状腺素检查结果、ESS与死亡的关系.结果 肺心病急性加重期ESS发生率42.5%(85/200);观察组入院时T3、FT3低于对照组;观察组中存活和病死比较,TSH无显著性差异外、病死患者T3、FT3、T4、FT4均低于存活患者(P＜0.05);原发病治疗好转后,甲状腺素可恢复或接近正常;发生ESS病死率30.59%.高于未发生变化的病死率13.04%.结论 血清甲状腺素水平变化反映了肺心病急性加重期患者的全身状态和严重程度,动态检测血清中甲状腺素水平可以预测肺心病的发展和转归.
目的 探討肺源性心髒病(肺心病)急性加重期患者甲狀腺功能的變化特點及意義.方法 肺心病急性加重期200例作為觀察組,同期健康體檢者200例作為對照組,觀察正常甲狀腺病態綜閤徵(ESS)髮生情況,對比對照組與觀察組中存活、病死患者的甲狀腺素水平,ESS者治療前後甲狀腺素檢查結果、ESS與死亡的關繫.結果 肺心病急性加重期ESS髮生率42.5%(85/200);觀察組入院時T3、FT3低于對照組;觀察組中存活和病死比較,TSH無顯著性差異外、病死患者T3、FT3、T4、FT4均低于存活患者(P＜0.05);原髮病治療好轉後,甲狀腺素可恢複或接近正常;髮生ESS病死率30.59%.高于未髮生變化的病死率13.04%.結論 血清甲狀腺素水平變化反映瞭肺心病急性加重期患者的全身狀態和嚴重程度,動態檢測血清中甲狀腺素水平可以預測肺心病的髮展和轉歸.
목적 탐토폐원성심장병(폐심병)급성가중기환자갑상선공능적변화특점급의의.방법 폐심병급성가중기200례작위관찰조,동기건강체검자200례작위대조조,관찰정상갑상선병태종합정(ESS)발생정황,대비대조조여관찰조중존활、병사환자적갑상선소수평,ESS자치료전후갑상선소검사결과、ESS여사망적관계.결과 폐심병급성가중기ESS발생솔42.5%(85/200);관찰조입원시T3、FT3저우대조조;관찰조중존활화병사비교,TSH무현저성차이외、병사환자T3、FT3、T4、FT4균저우존활환자(P＜0.05);원발병치료호전후,갑상선소가회복혹접근정상;발생ESS병사솔30.59%.고우미발생변화적병사솔13.04%.결론 혈청갑상선소수평변화반영료폐심병급성가중기환자적전신상태화엄중정도,동태검측혈청중갑상선소수평가이예측폐심병적발전화전귀.
Objective To investigate pulmonary heart disease acute exacerbation of changes in the characteristics of thyroid function and significance. Methods Pulmonary heart disease with acute exacerbation of 200 cases as the observation group,in the same period 200 cases of healthyas control group, observation euthyroid sick syndrome (euthyroid sick syndrome, ESS) occurred, compared the observe and control groups, observer group in the survival group died with the group,ESS thyroid hormone treatment before and after the test results,ESS and death. Results Pulmonary heart disease with acute exacerbation of ESS incidence of 42. 5% (85/200) ;section observe the admission T3 ,FT3 lower than the control group;observer group in the survival group died and TSH group no significant difference,the group died T3 ,FT3 ,T4 ,FT4 were lower than the survival group( P＜0. 05 ) ;improvement in the treatment of primary disease, thyroid hormone, or return to near normal ; ESS mortality occurred in 30. 59% higher than a change of 13.04% mortality rate. Conclusion Serum thyroid hormone levels to reflect changes in the pulmonary heart disease in patients with acute exacerbation of the state of the body and severity of the dynamic serum levels of thyroid hormone can observe the development of pulmonary heart disease and prognosis.
